Lenz Therapeutics’ Eye Drop Helps Improve Vision in Late-stage Study
(Reuters) -Lenz Therapeutics said on Wednesday its lead experimental drug being tested in patients with a common age-related eye disorder ...
Read more(Reuters) -Lenz Therapeutics said on Wednesday its lead experimental drug being tested in patients with a common age-related eye disorder ...
Read moreBerlin, Germany, San Diego, CA, USA, September 18, 2023 – Vividion Therapeutics, Inc. (Vividion), announced today that it has initiated ...
Read morePatients meeting the selection criteria are currently being pre-screened for entry into the Phase 2 Depression trialEthics and clinical trials ...
Read moreBig Health, a developer of digital therapeutics for insomnia and anxiety, is acquiring Limbix and its SparkRx adolescent depression therapeutic. ...
Read moreCAMBRIDGE, Mass., May 31, 2022 - BlueRock Therapeutics LP, a clinical stage biopharmaceutical company and wholly-owned subsidiary of Bayer AG, ...
Read moreSAN DIEGO - June 23, 2022 - Vividion Therapeutics, Inc., a biopharmaceutical company utilizing novel discovery technologies to unlock high ...
Read moreAbeona Therapeutics (Nasdaq: ABEO), a clinical-stage biopharmaceutical firm based in Cleveland, announced it has raised $25 million from "select existing ...
Read more© 2023 earth-news.info